Evidence map›Paper›PMID 38907929›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Delivery of mRNA with Histidine-Lysine Peptides.

Qixin Leng, Jiaxi He, Aishwarya Anand, A James Mixson

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. pH modification of gel mobility shift improves polyplex selection In Vivo.Biochemical and biophysical research communications · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qixin LengDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
Jiaxi HeDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
Aishwarya AnandDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
A James MixsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA. JMixson@som.umaryland.edu.

Funding

Developing nanoplexes for RNAi-expressing plasmidsR01EB028534 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE · PI MIXSON, ARCHIBALD JAMES · 2019 to 2023
$1.4M
NIBIB NIH HHS R01 EB028534
6 · The paper itself

Abstract

Transfection with mRNA has been considered superior to that with plasmids since the mRNA can be translated to a protein in the cytosol without entering the nucleus. One disadvantage of using mRNA is its susceptibility to enzymatic biodegradability, and consequently, significant research has occurred to determine nonviral carriers that will sufficiently stabilize this nucleic acid for cellular transport. Histidine-lysine peptides (HK) are one such class of mRNA carriers, which we think serves as a model for other peptides and polymeric carrier systems. When the HK peptide and mRNA are mixed and interact through ionic and nonionic bonds, mRNA polyplexes are formed, which can transfect cells. In contrast to linear HK peptides, branched HK peptides protected and efficiently transfected mRNA into cells. After describing the preparation and biophysical characterization of these polyplexes, we will provide protocols for in vitro and in vivo transfection for these mRNA polyplexes.

Indexed as

HistidineLysinePeptidesRNA, MessengerTransfectionAnimalsHumansHistidineLysinePeptidesRNA, MessengerHistidineImidazoleLipopolyplexesLiposomesLysinemRNAPeptidesPolymersPolyplexes

Identifiers

PMID38907929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.